Skip to content

management of orthodontic pain

Comparative effect of Ketoprofen chewing gums and ketoprofen gel in reducing orthodontic pain

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016121916466N5
Enrollment
85
Registered
2017-04-23
Start date
2010-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

orthodontic pain. Factors influencing health status and contact with health services

Interventions

Intervention 1: ketoprofen chewing gum group:Ketoprofen chewing gum at a dose of 100 mg per gum was made in the laboratory of Research and Development unit of Minoocompany.Patients immediately after
Treatment - Drugs
Placebo
ketoprofen chewing gum group:Ketoprofen chewing gum at a dose of 100 mg per gum was made in the laboratory of Research and Development unit of Minoocompany.Patients immediately after each orthodontic
ketoprofen gel group:The gel at a dose of 160mg per 100 ml after being made were loaded in 30g containers and ready to use.Patients immediately after each orthodontic treatment and then every 8 hours
placebo group:Placebo gum with the same flavor, form and packaging quite similar to medicated chewing gum was produced.Patients immediately after each orthodontic treatment and then every 8 hours unt

Sponsors

vice chancellor for research Shahid Beheshti Universiy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 25 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria : orthodontic patients reported pain in their previous meetings; Patients did not have any pain in the mouth (teeth and gums) at baseline; Patients must not use analgesics at baseline the study; Patients did not have severe liver or kidney disease or any other contraindications for using the considered drugs; Patients were at leveling stage in orthodontic treatment. exclusion criteria:Patients who did not complete the questionnaire at all recommended times ; used other analgesics during the study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: 2 h, 6h, 24h, day2(10am and 6 pm), day3(10am and 6 pm) and day7(10 am and 6 pm). Method of measurement: 5 score visual analogue scale( VAS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Dehghani

Shahid Beheshti Universiy of Medical Sciences

dehghanifatemeh65@yahoo.com+98 21 2990 2304

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026